Skip to content
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact

The Antigen Design
Platform

  • Antibody Generation
  • Antigen Design
  • OmniRat
  • OmniMouse
  • OmniChicken
  • OmnidAb
  • OmniTaur
  • Bispecific Platforms

Proven success with high-value and difficult targets

OmniAb offers computationally powered antigen design for challenging therapeutic targets. The antigen platform produces full-length membrane proteins, including multi-Tm proteins such as ion channels and G protein-coupled receptors (GPCRs), a large and important class of therapeutic drug targets.

Antigen production works in tandem with our therapeutic antibody discovery platform, providing access to high-quality, functionally validated membrane protein antigens for immunization campaigns.

Multi-faceted antigen design leverages years of experience and a range of technologies.

Guided by molecular modeling and protein design capabilities, our antigen solutions team manages the cloning, expression, purification, reconstitution, and quality control of purified native-conformation membrane proteins for immunization and screening purposes.

Designer antigens to stimulate the right immune response 

Antigens can be prepared in particular conformations with protein or small molecule conformational chaperones. The range of accessible protein antigen formats maximizes the chance of success in generating robust immune responses with desired specificities from any of the OmniAb antibody platforms.

Important factors you should take into consideration

There are a number of factors to keep top of mind when engaged in antigen design for antibody discovery.

For example, how complex is the antigen? This will affect how complex the antibody will be.

Another issue is what host animal is being used, such as rats, mice, or chickens. They all deliver a different mix of antibodies.

It’s also important to consider the nature of the application you need the antigens for and what is the most appropriate sequence involved in reaching your antigen goal. Above all, you want to keep out of the mix any epitopes that won’t work because of how they are structured.

We will be happy to consult with you if you have questions about designing antigens.

Frequently asked questions about designing antigens

We often receive inquiries from our partners. Here are answers to some of the most frequently asked questions regarding antigens and OmniAb:

What details do we need to provide to obtain antigens?

We’ll need to know about any special storage requirements for antigens, whether there are safety precautions we must observe, and what the culture protocol is (when using a cell line). Our scientists also must know about antigen format, whether whole cell, soluble protein, or DNA, for example.

How pure are the antigens?

We generally achieve a purity rate exceeding 90%.

What types of membrane proteins are suitable for an antigen?

A variety of formats are suitable, such as lipoparticles, nanodiscs, polymers, and proteoliposomes. Contact our team if you have specific membrane questions.

Scientific publications

For additional technical details and more context about the work we do in regard to designing antigens, read here.

Multi-faceted antigen design leverages years of experience and a range of technologies

Use modeling and design, cloning, expression, purification, reconstitution, quality control of highly purified native membrane proteins and immunizations, and other antigen production methods.

Designer Antigens to Stimulate the Right Immune Response

Display antigen in particular conformations with protein or small molecule conformational chaperones. The high quality, stability, and variety of available formats maximize the chance of success in generating robust immune response with any of the OmniAb antibody platforms.

About

  • Team
  • Board of Directors
  • Careers

Partnerships

  • Overview
  • Why Partner with OmniAb?
  • Partner Pipeline
  • Contact Business Development

Technology

  • Overview
  • Antigen Design
  • Antibody Generation
  • Antibody Optimization
  • Ion Channel and Transporter Technology
  • Scientific Publications

OmniAb, Inc.
5980 Horton Street
Suite 600
Emeryville, CA 94608

Contact | Privacy Policy | Disclaimer

© 2025 OmniAb, Inc. All rights reserved.